SLC12A6
protein-codingsolute carrier family 12 member 6, the group of Solute carrier family 12
Gene summary
This gene is a member of the K-Cl cotransporter (KCC) family. K-Cl cotransporters are integral membrane proteins that lower intracellular chloride concentrations below the electrochemical equilibrium potential. The proteins encoded by this gene are activated by cell swelling induced by hypotonic conditions. Alternate splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are associated with agenesis of the corpus callosum with peripheral neuropathy. [provided by RefSeq, Jul 2008]
- KCC3
- ACCPN
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~108.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0031068
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0000902
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0000902
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0031068
Submitter: Natera
Inheritance Pattern: AD
Disease ID:MONDO:0000902
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0000902
Submitter: Natera
Inheritance Pattern: AD
Disease ID:MONDO:0031068
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0000902
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0000902
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLC12A6 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001365088.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 28 | 464 | 6 | 499 | |
| missense | 5 | 14 | 464 | 10 | 1 | 494 |
| nonsense | 23 | 36 | 3 | 62 | ||
| start loss | 3 | 3 | ||||
| frameshift | 31 | 85 | 2 | 118 | ||
| splice donor/acceptor (+/-2bp) | 5 | 48 | 8 | 61 | ||
| Total | 64 | 184 | 508 | 474 | 7 | 1237 |
Highest pathogenic variant AF is 0.000028514187
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001352017.1 | 25 | MANE Select | |
| Ensembl | ENSP00000346112.3 | 25 | MANE Select | |
| RefSeq | NP_001035959.1 | 25 | Standard | |
| RefSeq | NP_001035960.1 | 25 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Polythiazide Action Pathway
- Methyclothiazide Action Pathway
- Bumetanide Action Pathway
- Spironolactone Action Pathway
- Eplerenone Action Pathway
Biological Process
- angiogenesis
- ion transport
- cell volume homeostasis
- chemical synaptic transmission
- chloride ion homeostasis
Molecular Function
- potassium:chloride symporter activity
Cellular Component
- plasma membrane
- integral component of plasma membrane
- integral component of membrane
- basolateral plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000354181
- Coding exons
- 25
- Length
- 104802
- Individuals with no LoFs
- 125685
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 63
- Defined
- 125748
- p
- 0.000251
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.96 | 436 | 648 | 0.673 | 0.0000374 | 7527 |
| Missense (PolyPhen) | 157 | 327.53 | 0.47935 | 3835 | ||
| Synonymous | 0.0760 | 228 | 229 | 0.994 | 0.0000129 | 2293 |
| Loss of Function | 5.49 | 17 | 64.6 | 0.263 | 0.00000415 | 687 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.00067 | 0.00067 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.00018 | 0.00018 | rare |
| European (Non-Finnish) | 0.00020 | 0.00020 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Mediates electroneutral potassium-chloride cotransport. May be activated by cell swelling. May contribute to cell volume homeostasis in single cells.;
- Disease
- DISEASE: Agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) [MIM:218000]: A disease that is characterized by severe progressive sensorimotor neuropathy, mental retardation, dysmorphic features and complete or partial agenesis of the corpus callosum. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.262
Intolerance Scores
- LoFtool
- 0.0254
- RVIS EVS
- -1.13
- RVIS percentile EVS
- 6.51
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.393
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |